bextra

Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) and the Department of Justice have reached an agreement in principle to the illegal marketing practices of antipsychotic drug Risperdal. In the drug maker's securities filing it indicated “issues remain open” before settlements can be...